Professor Mohammad Abdollahi was born in 1965, in the city of Rasht, North of Iran, where he graduated from high school. Since 1983, he moved to Tehran and first studied Pharmacy in University of Tehran (now Tehran University of Medical Sciences). He received his PharmD in 1988. Professor Abdollahi continued his studies in the field of Pharmacology and Toxicology, and consequently was awarded a doctorate by Tehran University of Medical Sciences (TUMS) in 1994. In the year 2000, Mohammad moved to University of Toronto in Canada and studied in several fields of Toxicology. Professor Abdollahi completed his postdoctoral fellowship in Mechanistic Toxicology, and returned to Tehran in 2001. Professor Abdollahi became the youngest Full Professor at Tehran University of Medical Sciences in 2003. Professor Abdollahi has supervised more than 300 graduate and over 100 postgraduate students. He has published over 500 high-impact-full papers [1], and contributed to 22 books, from famous publishers, like Elsevier, Wiley, Mc-Graw Hill, Springer, Academic Press, etc. He is listed as the top scientist of Iran and one of the tops of the Middle East, and yet one of the tops of Asia in some specific areas [2]. Total GS citations of Professor Abdollahi in textbooks and journals is over 8000. His current h-index is 46 in Google Scholar, 42 in Scopus/Elsevier, and 33 in Thompson Reuters ISI. Professor Abdollahi has been involved in establishing [http://apps.who.int/medicinedocs/en/d/Js2248e/8.html Iran's Drug and Poison Information Centers], and was Manager of Tehran’s center for 6 years ^[1]. Professor Abdollahi has also cooperated with World Health Organization, in the sections of pesticide, Drug and Poison Information Centers, and lead poisonings. Mohammad is also a scientific advisory board of Organisation for Prohibition of Chemical Weapons (OPCW) [3] based in the Netherlands. Mohammad is a correspondent to World Library of Toxicology ^[2]. MA participated in the WHO/FAO Joint Meeting on Pesticide Residues (JMPR) as an expert adviser during 2005-2012 and currently advising WHO on the development of Guidelines for the Prevention and Management of Lead Poisoning.Since March 2013, Mohammad has been elected as a Council Trustee Member of COPE (Committee on Publication Ethics) [4] based in UK.

Professor Abdollahi’s research interest includes: Evidence-Based Medicine; Clinical studies; Mechanistic Toxicology; Oxidative Stress; Colitis; Metabolism of glucose and diabetes; Phosphodiesterase inhibitors; Pesticides; Meta-analysis; and Epidemiology of poisonings--
one of the research interests of Mohammad is the mechanisms relating chronic exposure to toxic compounds and the induction of debilitating human diseases. To promote this idea, Mohammad established a multitude of animal disease models, and carried out mechanistic studies in the field of toxicology and disease biomarkers. He is one of the pioneers in the field of oxidative stress, a toxicological mechanism which plays a role in many human debilitating diseases. Three of Mohammad’s review papers in this area ^{[3] [4] [5]} are the most highly-cited articles dealing with the relationship of oxidative stress and diabetes, inflammatory bowel disease, and pesticide exposure. The outcomes of these studies have resulted in production of new drugs for such diseases. One of Mohammad’s theories is that synergistic effects of natural or synthetic compounds, with anti-oxidative effects, and formulating such mixtures may result in protection against diabetes and human inflammatory bowel disease, and also diminishing toxicity of xenobiotics. Now Mohammad is elucidating the elements and mechanisms that are involved in such relationship. Studies of Mohammad give the hope that new drugs with natural origin in synergistic effects would control some oxidant-related phenomenon like age-related disorders ^[6].

Professor Abdollahi has been a recipient of many awards, including: Excellent Researcher Award of Tehran University of Medical Sciences, 1997; Prizer of Ebnesina Festival Award in Education, Tehran University of Medical Sciences, 1999; Young Scientist Fellowship in VII World Conference on Clinical Pharmacology and Therapeutics (IUPHAR) Division of Clinical Pharmacology, and the 4th Congress of theeeeeeeee European Association for Clinical Pharmacology and Therapeutics (EACPT), Florence, Italy, 2000; First-Ranked winner of Razi National Research Festival Award of Medical Sciences in Student Program, as Supervisor, 2001; Young Scientist Fellowship in the 39th Congress of European Associations of Toxicology (EUROTOX), Istanbul, Turkey, 13-16 September 2001; Young Scientist Fellowship in the 38th Congress of European Associations of Toxicology (EUROTOX), London, England, 2001; First-Ranked Winner of Razi National Research Festival Award of Medical Sciences, 2002; Young Scientist Fellowship in the 38th Congress of European Associations of Toxicology (EUROTOX) Budapest, Hungry, 2002; Leading Scientist of the Ministry of Health, Deputy of Education, National Medical Board Members, 2003; Leading Scientist of the 6th Annual Festival in Honor of the Distinguished Researchers of the Year, Ministry of Science, Research, & Technology, 2005; Laureate of the Islamic World Academy of Sciences (IAS) and OIC Standing Committee on Scientific and Technological CO-Operation (COMSTECH) in Pharmacology & Toxicology, 2005 ^[7]; Leading Scientist Prizer of Ebnesina Festival Award, Tehran University of Medical Sciences, 2008; Leading Scientist of OIC member statutes selected by COMSTECH, 2007; Winner of the 2008 Islamic-World Academy of Sciences (IAS) Fellowship Election; TWAS (The Academy of Sciences for the Developing World) Regional Office for Central and South Asia; Young Scientists of Asia Conclave 2009 at Bangalore, India, January 15-17 2009 ^[8]; Honorary Academic Member of Iranian Farzan Medical Scientific Institute; ^[9] Laureate of the 14th RAZI International Research Festival on Medical Sciences, December 2008, Tehran, organized by NRCMS and ISESCO; ^[10] Listed among 1% top scientists of the World ^[11] as reported by Essential Science Indicator of Thompson Reuter ISI. Honorary Academic Member of Islamic Azad University, Pharmaceutical Branch, Tehran; Laureate of the 15th RAZI International Research Festival on Medical Sciences, December 2009, Tehran, organized by NRCMS and ISESCO; First Class Medal as Leading Scientist of University of Tehran Festival of Research, December 2009; Leading Scientist of the 10th Annual Festival in Honor of the Distinguished Researchers of the Year, Ministry of Science, Research, & Technology, December 2009. In 2012 he was awarded as the top scientist of Iran recognized by National Elite Foundation and also awarded by Iranian Academy of Medical Sciences as the decade top scientists of Iran [5].

mr. Professor Abdollahi is a member of Committee on Publication Ethics (COPE) 2009-present and a COPE Council Trustee Member since 2013 [6]; European Association of Science Editors (EASE), 2011-present; Association of European Toxicologists and European Societies of Toxicology (EUROTOX), 2008-present; European Association of Poisons Centers and Clinical Toxicologists (EAPCCT), 2009-present; The Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group, 2009-present; The Cochrane Pregnancy and Childbirth Group, 2009-present; International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 2007-present; Islamic-World Academy of Sciences (IAS, Fellow), 2008-present; Society for Free Radical Research International, 2008-present; Asia Pacific Association of Medical Toxicology (APAMT), 2007-present; World Association of Medical Editors (WAME), 2004-present; American Academy of Clinical Toxicology (AACT) 2006-present; [http://irantox.net/ (IranTox], President), 2005-present; and Country Correspondent to World Library of Toxicology (WLT) [7] 2008-present.

Professor Abdollahi is an editorial board member of many prestigious national and international journals, including: Archives of Industrial Hygiene and Toxicology (Croatia)2008-present; Archives of Medical Science (Associate Editor) (Poland), 2007-present; Case Reports in Medicine (Editor) (USA), 2006-2012; DARU Journal of Pharmaceutical Sciences (Associate Editor 2002-2011; and Editor-in-Chief 2011-continued) [8] (BioMed Central), International Journal of Biomedical Science Editing (BioSciEdit) (Netherlands), 2011-present; International Journal of Nanomedicine (USA), 2009-present; Journal of Medical Hypotheses and Ideas (Editor-in-Chief)(Elsevier), 2007-present; Journal of Dentistry, TUMS (Iran), 2004-present; Journal of Environmental Protection Science (USA), 2005-present; Journal of Faculty of Medicine, Babol University of Medical Sciences (Iran), 2003-present; Research in Pharmaceutical Sciences (Iran), 2005-present; Iranian Journal of Basic Medical Sciences (2012-present); World Journal of Diabetes (China), 2009-present; and World Journal of Gastroenterology (China), 2008-present; Oxidative Medicine and Cellular Injury (USA), 2012-continued. Professor Abdollahi is also a reviewer for more than one hundred highly impact journals. Mohammad is associate editor for the 3rd edition of the reference text book “ Encyclopedia of Toxicology” being published in USA by Elsevier and Co-Editor-in-Chief to the book "Basci and Clinical Toxicology of Organophosphorus Compounds" being published by Springer. Mohammad believes Iranians must honor to their history “the golden time of Persian science”since Persian scientists contributed a lot to the current understanding of nature, medicine, mathematics, philosophy, algebra, and chemistry. Mohammad believes that science is global and not limited to borders and countries; so scientists should cooperate and dialogue mutually to improve the global science.Mohammad believes, successful Iranians in the field of science, wherever they are, always make him proud.

1. http://digicollection.org/hss/en/d/Js2248e/8.html
2. http://toxipedia.org/display/wlt/Mohammad+Abdollahi
3. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother. 2005 Aug;59(7):365-73. Review. PMID  16081237.
4. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig Dis Sci. 2007 Sep;52(9):2015-21. Epub 2007 Apr 3. Review. PMID  17404859.
5. Pesticides and oxidative stress: a review. Med Sci Monit. 2004 Jun;10(6):RA141-7. Epub 2004 Jun 1. Review. PMID  15173684.
6. A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases. Inflamm Allergy Drug Targets. 2009 Mar;8(1):2-10. Review. PMID  19275687.
7. http://www.iasworld.org/html/ibrahim_award_laureats.html
8. http://www.jncasr.ac.in/twasrocasa
9. www.farzaninstitute.com
10. http://razi.research.ac.ir/forms/about.aspx
11. http://www.researcherid.com/rid/B-9232-2008